Shanghai Obio Technology (Group) (SHSE:688238) Piotroski F-Score: 5 (As of Jul. 03, 2026) — 25% Above Median


SHSE:688238 Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
63 GF Score
Price ¥5.82
GF Value ¥7.80
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Obio Technology (Group) Piotroski F-Score?

Shanghai Obio Technology (Group) SHSE:688238 +5.82% 63 Piotroski F-Score is 5 as of Jul. 03, 2026, which is 25% above its 10-year median of 4.00. GuruFocus rates SHSE:688238 with a GF Score™ of 63/100 and a GF Value™ of ¥7.80 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,336 Biotechnology companies, Shanghai Obio Technology (Group) ranks better than 84.96% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Obio Technology (Group) has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shanghai Obio Technology (Group)'s Piotroski F-Score or its related term are showing as below:

SHSE:688238' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 6
Current: 5

During the past 12 years, the highest Piotroski F-Score of Shanghai Obio Technology (Group) was 6. The lowest was 1. And the median was 4.

Shanghai Obio Technology (Group)  (SHSE:688238) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shanghai Obio Technology (Group) Piotroski F-Score Related Terms


Shanghai Obio Technology (Group) Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shanghai Obio Technology (Group)'s Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Obio Technology (Group) Piotroski F-Score Chart

Shanghai Obio Technology (Group) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 1.00 4.00 5.00

Shanghai Obio Technology (Group) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 3.00 5.00 5.00

SHSE:688238 vs VRTX, REGN, ALNY: Piotroski F-Score Comparison

For the Biotechnology subindustry, Shanghai Obio Technology (Group)'s Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Obio Technology (Group) Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Obio Technology (Group)'s Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shanghai Obio Technology (Group)'s Piotroski F-Score falls into.


SHSE:688238
63GF Score
Shanghai Obio Technology (Group) Corp Ltd SHSE:688238
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -45.093 + -57.543 + -72.949 + -53.085 = ¥-228.7 Mil.
Cash Flow from Operations was -27.086 + -22.081 + 7.986 + -66.072 = ¥-107.3 Mil.
Revenue was 67.007 + 60.499 + 87.343 + 50.54 = ¥265.4 Mil.
Gross Profit was 2.139 + -13.085 + -8.668 + -12.052 = ¥-31.7 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(2194.351 + 2119.453 + 2116.972 + 2091.792 + 1998.178) / 5 = ¥2104.1492 Mil.
Total Assets at the begining of this year (Mar25) was ¥2,194.4 Mil.
Long-Term Debt & Capital Lease Obligation was ¥181.5 Mil.
Total Current Assets was ¥473.4 Mil.
Total Current Liabilities was ¥368.9 Mil.
Net Income was -71.175 + -76.421 + -132.046 + -59.477 = ¥-339.1 Mil.

Revenue was 53.487 + 70.806 + 64.282 + 52.848 = ¥241.4 Mil.
Gross Profit was -14.949 + -12.864 + -53.47 + -19.259 = ¥-100.5 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(2568.964 + 2482.515 + 2353.301 + 2284.741 + 2194.351) / 5 = ¥2376.7744 Mil.
Total Assets at the begining of last year (Mar24) was ¥2,569.0 Mil.
Long-Term Debt & Capital Lease Obligation was ¥120.0 Mil.
Total Current Assets was ¥611.6 Mil.
Total Current Liabilities was ¥365.8 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Obio Technology (Group)'s current Net Income (TTM) was -228.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Obio Technology (Group)'s current Cash Flow from Operations (TTM) was -107.3. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-228.67/2194.351
=-0.10420849

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-339.119/2568.964
=-0.13200613

Shanghai Obio Technology (Group)'s return on assets of this year was -0.10420849. Shanghai Obio Technology (Group)'s return on assets of last year was -0.13200613. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shanghai Obio Technology (Group)'s current Net Income (TTM) was -228.7. Shanghai Obio Technology (Group)'s current Cash Flow from Operations (TTM) was -107.3. ==> -107.3 > -228.7 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=181.473/2104.1492
=0.08624531

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=120.023/2376.7744
=0.05049827

Shanghai Obio Technology (Group)'s gearing of this year was 0.08624531. Shanghai Obio Technology (Group)'s gearing of last year was 0.05049827. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=473.392/368.906
=1.28323204

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=611.596/365.803
=1.67192724

Shanghai Obio Technology (Group)'s current ratio of this year was 1.28323204. Shanghai Obio Technology (Group)'s current ratio of last year was 1.67192724. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shanghai Obio Technology (Group)'s number of shares in issue this year was 631.962. Shanghai Obio Technology (Group)'s number of shares in issue last year was 646.492. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-31.666/265.389
=-0.11931919

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-100.542/241.423
=-0.41645576

Shanghai Obio Technology (Group)'s gross margin of this year was -0.11931919. Shanghai Obio Technology (Group)'s gross margin of last year was -0.41645576. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=265.389/2194.351
=0.12094191

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=241.423/2568.964
=0.09397679

Shanghai Obio Technology (Group)'s asset turnover of this year was 0.12094191. Shanghai Obio Technology (Group)'s asset turnover of last year was 0.09397679. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+1+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Obio Technology (Group) has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Shanghai Obio Technology (Group) (SHSE:688238) has a Piotroski F-Score of 5 as of Jul. 03, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Obio Technology (Group) and its competitors. This is 25% above median its historical median of 4.00. Over the past decade, Shanghai Obio Technology (Group)'s Piotroski F-Score has ranged from 1.00 to 6.00. According to the industry distribution chart, Shanghai Obio Technology (Group) ranks #201 out of 1336 companies in the Biotechnology industry, placing it in the top 15%.
Is Shanghai Obio Technology (Group)'s Piotroski F-Score too high?
Shanghai Obio Technology (Group)'s current Piotroski F-Score of 5 is 25% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 6.00. The Biotechnology industry median Piotroski F-Score is 3.00. Shanghai Obio Technology (Group)'s value of 5 is 66.7% above this industry median. Based on the distribution chart, Shanghai Obio Technology (Group) ranks #201 out of 1336 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Obio Technology (Group) has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Obio Technology (Group)'s Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Obio Technology (Group) ranks #201 out of 1336 companies for Piotroski F-Score. This places Shanghai Obio Technology (Group) in the top 15% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 3.00. Shanghai Obio Technology (Group)'s value of 5 is 66.7% above this benchmark. Historically, Shanghai Obio Technology (Group)'s own Piotroski F-Score has ranged from 1.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 3.00, Shanghai Obio Technology (Group) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,336 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Obio Technology (Group)'s current Piotroski F-Score of 5 is 66.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Obio Technology (Group) and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Obio Technology (Group)'s current Piotroski F-Score is 5, which is 25% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Obio Technology (Group) stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Obio Technology (Group) (SHSE:688238) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.80, compared to a current price of ¥5.82 — trading 25.4% below its estimated fair value. The current Piotroski F-Score is 5, which is 25% above median its 10-year median of 4.00 and 66.7% above the Biotechnology industry median of 3.00. Shanghai Obio Technology (Group)'s overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai Obio Technology (Group) (SHSE:688238), the current Piotroski F-Score is 5 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Obio Technology (Group) (SHSE:688238) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Obio Technology (Group) stock appears to be undervalued. The current stock price of ¥5.82 is trading 25.4% below its estimated GF Value™ of ¥7.80. GuruFocus considers Shanghai Obio Technology (Group) to be Modestly Undervalued.

Key valuation signals for SHSE:688238:

  • Piotroski F-Score: 5 (25% above median its 10-year median of 4.00)
  • GF Value™: ¥7.80 vs. price of ¥5.82 (25.4% below fair value)
  • GF Score™: 63/100 with 5 warning signs
  • Industry Position: 66.7% above the Biotechnology median (#201 of 1336)

No single metric tells the full story. See the SHSE:688238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Obio Technology (Group) Business Description

Address Lane 908, Ziping Road, Building 19, International Medical Park, Pudong New Area, Shanghai, CHN, 201318
Shanghai Obio Technology (Group) Corp Ltd provides contract research organization (CRO) services, including gene therapy vector development and gene function research for basic research, as well as contract development and manufacturing organization (CDMO) services, including IND-enabling CMC research and GMP production of clinical samples for gene therapy drug development.
63GF Score

Get the complete analysis for SHSE:688238

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.82
Price
¥7.80
GF Value